BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32629871)

  • 1. NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by Suppressing HO-1 and ABCG2 Expression.
    Kim EJ; Kim YJ; Lee HI; Jeong SH; Nam HJ; Cho JH
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions.
    Sasaki N; Ishiwata T; Hasegawa F; Michishita M; Kawai H; Matsuda Y; Arai T; Ishikawa N; Aida J; Takubo K; Toyoda M
    Cancer Sci; 2018 Apr; 109(4):1135-1146. PubMed ID: 29444383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.
    Hong YB; Kang HJ; Kwon SY; Kim HJ; Kwon KY; Cho CH; Lee JM; Kallakury BV; Bae I
    Pancreas; 2010 May; 39(4):463-72. PubMed ID: 20118824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
    Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
    Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.
    Kang KA; Piao MJ; Kim KC; Kang HK; Chang WY; Park IC; Keum YS; Surh YJ; Hyun JW
    Cell Death Dis; 2014 Apr; 5(4):e1183. PubMed ID: 24743738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
    Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.
    Arfmann-Knübel S; Struck B; Genrich G; Helm O; Sipos B; Sebens S; Schäfer H
    PLoS One; 2015; 10(7):e0132978. PubMed ID: 26226105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
    Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
    BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
    Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
    BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway.
    Li H; Jiang W; Liu XN; Yuan LY; Li TJ; Li S; Xu SS; Zhang WH; Gao HL; Han X; Wang WQ; Wu CT; Yu XJ; Xu HX; Liu L
    Oncogene; 2020 Sep; 39(36):5825-5838. PubMed ID: 32753651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.
    Li PC; Tu MJ; Ho PY; Jilek JL; Duan Z; Zhang QY; Yu AX; Yu AM
    Drug Metab Dispos; 2018 Jan; 46(1):2-10. PubMed ID: 29061583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells.
    Grattarola M; Cucci MA; Roetto A; Dianzani C; Barrera G; Pizzimenti S
    Free Radic Biol Med; 2021 Oct; 174():202-210. PubMed ID: 34364982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells.
    Kang KA; Piao MJ; Ryu YS; Kang HK; Chang WY; Keum YS; Hyun JW
    Oncotarget; 2016 Jun; 7(26):40594-40620. PubMed ID: 27259240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.
    Kweon MH; Adhami VM; Lee JS; Mukhtar H
    J Biol Chem; 2006 Nov; 281(44):33761-72. PubMed ID: 16950787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.
    Hagiya Y; Adachi T; Ogura S; An R; Tamura A; Nakagawa H; Okura I; Mochizuki T; Ishikawa T
    J Exp Ther Oncol; 2008; 7(2):153-67. PubMed ID: 18771089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling.
    Tian S; Yong M; Zhu J; Zhang L; Pan L; Chen Q; Li KT; Kong YH; Jiang Y; Yu TH; Yu LH; Bai DQ
    Anticancer Agents Med Chem; 2017; 17(13):1824-1836. PubMed ID: 28356018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.
    Yang B; Ma YF; Liu Y
    Drug Res (Stuttg); 2015 Oct; 65(10):526-31. PubMed ID: 25368906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells.
    Zhang Z; Gao S; Xu Y; Zhao C
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.